Merit Medical Systems (NASDAQ:MMSI) Stock Rating Raised to “Strong-Buy” at Wall Street Zen

Merit Medical Systems (NASDAQ:MMSI – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a report issued on Saturday, Wall Street Zen reports.

Several other research analysts have also issued reports on the stock. Piper Sandler increased their price target on shares of Merit Medical Systems from $96.00 to $106.00 and gave the stock an “overweight” rating in a research report on Friday, July 31st. Needham & Company LLC raised their price target on shares of Merit Medical Systems from $101.00 to $106.00 and gave the stock a “buy” rating in a research note on Friday, October 30th. JPMorgan Chase & Co. lifted their price objective on Merit Medical Systems from $95.00 to $110.00 and gave the company an “overweight” rating in a report on Friday, October 30th. Bank of America upped their price objective on Merit Medical Systems from $92.00 to $97.00 and gave the company a “neutral” rating in a research note on Thursday, August 13th. Finally, Robert W. Baird set a $98.00 price objective on Merit Medical Systems in a research note on Friday, July 31st. Eight investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, Merit Medical Systems presently has a consensus rating of “Moderate Buy” and a consensus price target of $105.91.

Get Our Latest Research Report on MMSI

Merit Medical Systems Trading Down 0.0%

Shares of Merit Medical Systems stock opened at $84.39 on Friday. Merit Medical Systems has a 52-week low of $59.74 and a 52-week high of $94.85. The firm has a market capitalization of $5.06 billion, a PE ratio of 22.20, a price-to-earnings-growth ratio of 2.10 and a beta of 0.56. The company has a debt-to-equity ratio of 0.42, a current ratio of 4.52 and a quick ratio of 3.05. The company’s fifty day moving average price is $87.79 and its two-hundred day moving average price is $77.51.

Merit Medical Systems (NASDAQ:MMSI – Get Free Report) last released its quarterly earnings data on Thursday, October 29th. The medical instruments supplier reported $1.12 EPS for the quarter, topping analysts’ consensus estimates of $1.04 by $0.08. Merit Medical Systems had a net margin of 9.94% and a return on equity of 14.12%. The company had revenue of $416.24 million during the quarter, compared to the consensus estimate of $410.56 million. During the same period last year, the firm earned $0.92 EPS. The firm’s revenue for the quarter was up 8.4% compared to the same quarter last year. On average, analysts expect that Merit Medical Systems will post 3.86 EPS for the current year.

Insider Activity at Merit Medical Systems

In other news, insider Brian Lloyd sold 16,722 shares of the company’s stock in a transaction dated Monday, November 16th. The shares were sold at an average price of $86.33, for a total value of $1,443,610.26. Following the sale, the insider owned 60,132 shares of the company’s stock, valued at approximately $5,191,195.56. This represents a 21.76% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.70% of the company’s stock.

Hedge Funds Weigh In On Merit Medical Systems

Several institutional investors have recently added to or reduced their stakes in the company. American Century Companies Inc. grew its stake in Merit Medical Systems by 11.5% during the third quarter. American Century Companies Inc. now owns 103,089 shares of the medical instruments supplier’s stock worth $8,889,000 after buying an additional 10,667 shares during the last quarter. Cim Investment Management Inc. acquired a new stake in shares of Merit Medical Systems during the third quarter worth approximately $248,000. Kestra Advisory Services LLC acquired a new stake in shares of Merit Medical Systems during the third quarter worth approximately $339,000. Zacks Investment Management bought a new position in shares of Merit Medical Systems in the third quarter valued at approximately $536,000. Finally, Integrated Wealth Concepts LLC raised its stake in shares of Merit Medical Systems by 7.7% in the third quarter. Integrated Wealth Concepts LLC now owns 3,086 shares of the medical instruments supplier’s stock valued at $266,000 after acquiring an additional 220 shares during the last quarter. 99.66% of the stock is owned by institutional investors.

Merit Medical Systems Company Profile

(Get Free Report)

Merit Medical Systems develops, manufactures and markets medical devices used in diagnostic and interventional procedures. Its products support clinicians in areas including cardiology, radiology, oncology and endoscopy. The company’s portfolio includes devices and accessories for vascular access, diagnostic and therapeutic procedures, drainage, biopsy and embolization. Merit serves hospitals, clinics and other healthcare providers through direct sales and distribution channels. Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves customers in the United States and internationally.

Featured Articles

Analyst Recommendations for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.